CD103+ Ly6C+ DC-like antigen-presenting cells, which are derived from the monocytic lineage, have been suggested to be critical for initiating anti-tumor immune responses early during inflammatory conditions, for example when tumor cells die after chemotherapy or immunotherapy 43, 44. This evidence concerns the gene ITGAE and neoplasm.